Submit Deal

Announced

28 Feb 2023

Completed

28 Feb 2023

Elliminist Singapore completed the acquisition of Sagent Pharmaceuticals and Omega Laboratories from Nichi-Iko Pharmaceutical for $100m.

Synopsis

Elliminist Singapore completed the acquisition of Sagent Pharmaceuticals and Omega Laboratories from Nichi-Iko Pharmaceutical, a generic drug manufacturer, for $100m.

Principals

target

Nichi-iko (sagent Pharmaceuticals And Omega Laboratories)

bidder

Elliminist Singapore

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Vendor Team (12)

yuichi tamura

President and CEO at NICHI-IKO PHARMACEUTICAL

Manager

vendor

Deal

£ 83 M

Total Value

joanna fine

Partner at Osler Hoskin & Harcourt

Lawyer

vendor

Deals

£ 1.87 B

Total Value

susan newell

Partner at Osler Hoskin & Harcourt

Lawyer

vendor

Deals

£ 1.74 B

Total Value

gemma devir

Associate at Osler Hoskin & Harcourt

Lawyer

vendor

Deals

£ 179 M

Total Value

vincent m. de grandpré

Partner at Osler Hoskin & Harcourt

Lawyer

vendor

Deal

£ 83 M

Total Value

jeremy perron

Associate at Osler Hoskin & Harcourt

Lawyer

vendor

Deals

£ 6.35 B

Total Value

jean-philippe dionne

Associate at Osler Hoskin & Harcourt

Lawyer

vendor

Deals

£ 1.48 B

Total Value

jennifer fairfax

Partner at Osler Hoskin & Harcourt

Lawyer

vendor

Deals

£ 83 M

Total Value

julien ranger

Partner at Osler Hoskin & Harcourt

Lawyer

vendor

Deals

£ 6.25 B

Total Value

adam laroche

Associate at Osler Hoskin & Harcourt

Lawyer

vendor

Deals

£ 186 M

Total Value

shuli rodal

Partner at Osler Hoskin & Harcourt

Lawyer

vendor

Deals

£ 37.80 B

Total Value

yan a. besner

Partner at Osler Hoskin & Harcourt

Lawyer

vendor

Deals

£ 3.13 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy